S&P 500 7,387.05 â–ŧ 197.26 (-2.60%) DOW 50,877.30 â–ŧ 684.63 (-1.33%) NASDAQ 25,726.49 â–ŧ 1,104.47 (-4.12%) US Markets Closed â€ĸ 12:29 PM ET

WGRX

Wellgistics Health, Inc.

Price Chart
Latest Quote

$4.35

+0.06 (+1.40%)
Current Price
Previous Close $4.29
Open $4.17
Day High $4.40
Day Low $3.80
Volume 78,706
Fetched: 2026-06-05T22:36:37
Stock Information
Shares Outstanding 2.51M
Total Debt $28.73M
Cash Equivalents $52K
Revenue $14.03M
Net Income $-76.59M
Sector Healthcare
Industry Pharmaceutical Retailers
Market Cap $10.93M
EPS (TTM) $-44.00
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$39.60M
Sales$14.03M
Income$-76.59M
Book/sh$-0.12
Cash/sh$0.02
Financial Ratios
Quick Ratio0.03
Current Ratio0.09
Returns & Margins
ROA-79.18%
Gross Margin-49.51%
Operating Margin-385.72%
Ownership
Insider Ownership50.39%
Institutional Ownership1.72%
Insider & Institutional transactions data not available
Valuation Ratios
P/S0.78
P/B-35.37
Analyst Data
Recommendationnone
Technical Indicators
SMA20$4.74
SMA50$5.42
SMA200$24.09
RSI50.62
ATR1.8250
Shares Float814K
Short Float13.74%
Short Ratio0.78
Rel Volume0.05
Performance History
Week+27.19%
Month-6.45%
Quarter-47.27%
6 Months-84.68%
YTD-79.95%
Year-95.56%
10 Years-97.72%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-05 $4.35 78,800
2026-06-04 $4.29 74,000
2026-06-03 $4.39 59,500
2026-06-02 $4.25 138,200
2026-06-01 $3.85 259,400
2026-05-29 $3.42 300,900
2026-05-28 $3.72 9,810,800
2026-05-27 $3.16 286,700
2026-05-26 $3.82 306,400
2026-05-22 $4.15 268,446
2026-05-21 $5.35 371,708
2026-05-20 $6.45 2,580,474
2026-05-19 $8.40 1,563,864
2026-05-18 $8.70 12,850,362
2026-05-15 $4.20 102,598
2026-05-14 $4.70 249,914
2026-05-13 $4.85 3,729,316
2026-05-12 $3.95 48,464
2026-05-11 $4.60 43,584
2026-05-08 $4.20 62,044
2026-05-07 $4.40 41,194
2026-05-06 $4.65 76,032
About Wellgistics Health, Inc.

Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $29,764,279 $16,361,517 $0 $27,028,874
Cost Of Revenue $29,764,279 $16,361,517 $0 $27,028,874
Total Revenue $23,337,860 $18,128,831 $0 $32,777,728
Operating Revenue $23,337,860 $18,128,831 $0 $32,777,728
Expenses
Interest Expense $4,579,556 $831,467 $15,081 $287,183
Total Expenses $104,532,691 $24,273,963 $2,880,603 $36,200,457
Other Income Expense $-15,500,143 $120,373 $98,132 $966,112
Other Non Operating Income Expenses $42,045 $120,373 $180,461 $-851,942
Net Non Operating Interest Income Expense $-4,579,556 $-831,467 $-15,081 $-287,183
Interest Expense Non Operating $4,579,556 $831,467 $15,081 $287,183
Operating Expense $74,768,412 $7,912,446 $2,880,603 $9,171,583
Selling And Marketing Expense $1,224,521 $0 - -
General And Administrative Expense $70,332,827 $6,797,782 $2,880,603 $7,082,600
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Net Interest Income $-4,579,556 $-831,467 $-15,081 $-287,183
Normalized Income $-85,732,342 $-6,856,226 $-2,895,684 $-4,561,854
Net Income From Continuing And Discontinued Operation $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Total Operating Income As Reported $-93,749,097 $-6,145,132 $-2,880,603 $-3,422,729
Net Income Common Stockholders $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Net Income $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Net Income Including Noncontrolling Interests $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Net Income Continuous Operations $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Pretax Income $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Special Income Charges $-15,542,188 $0 - $1,818,054
Operating Income $-81,194,831 $-6,145,132 $-2,880,603 $-3,422,729
Depreciation Amortization Depletion Income Statement $3,211,064 $1,114,664 $0 $2,087,583
Depreciation And Amortization In Income Statement $3,211,064 $1,114,664 $0 $2,087,583
Gross Profit $-6,426,419 $1,767,314 $0 $5,748,854
Earnings From Equity Interest - - $-82,329 -
Per Share
Diluted EPS - $-0.15 $-0.06 $-0.06
Basic EPS - $-0.15 $-0.06 $-0.06
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-77,941,722 $-4,910,095 $-2,880,603 $-2,187,088
Total Unusual Items $-15,542,188 $0 - $1,818,054
Total Unusual Items Excluding Goodwill $-15,542,188 $0 - $1,818,054
Reconciled Depreciation $3,211,064 $1,114,664 $0 $2,087,583
EBITDA (Bullshit earnings) $-93,483,910 $-4,910,095 $-2,880,603 $-369,034
EBIT $-96,694,974 $-6,024,759 $-2,880,603 $-2,456,617
Diluted NI Availto Com Stockholders $-101,274,530 $-6,856,226 $-2,895,684 $-2,743,800
Tax Provision $0 $0 $0 $0
Other Special Charges $2,987,922 - - $-1,818,054
Impairment Of Capital Assets $12,554,266 $0 - -
Selling General And Administration $71,557,348 $6,797,782 $2,880,603 $7,082,600
Other Gand A $70,332,827 $6,797,782 $2,880,603 $7,082,600
Diluted Average Shares - $47,252,081 $44,720,000 $47,252,081
Basic Average Shares - $47,252,081 $44,720,000 $47,252,081
Research And Development - - $375 $1,400
Fetched: 2026-06-02
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-38,806,757 $-31,849,509 $-2,900,434 $-5,250
Total Assets $30,459,449 $57,332,650 $338,364 $0
Total Non Current Assets $27,640,233 $42,163,982 $0 $0
Non Current Prepaid Assets $85,008 $85,008 $0 -
Non Current Note Receivables $0 $139,771 $0 -
Goodwill And Other Intangible Assets $26,358,956 $38,583,955 $0 -
Other Intangible Assets $12,165,033 $22,364,026 - -
Current Assets $2,819,216 $15,168,668 $338,364 $0
Current Deferred Assets $0 $875,385 $0 -
Prepaid Assets $0 $524 $0 -
Inventory $1,639,426 $9,518,608 $0 -
Receivables $1,137,219 $3,745,814 $337,000 $0
Accounts Receivable $1,137,219 $2,724,814 $0 -
Allowance For Doubtful Accounts Receivable $-847,205 $-940,596 $0 -
Gross Accounts Receivable $1,984,424 $3,665,410 $0 -
Cash Cash Equivalents And Short Term Investments $42,571 $1,028,336 $1,364 $0
Cash And Cash Equivalents $42,571 $1,028,336 $1,364 $0
Other Non Current Assets - $1,438,940 - -
Other Current Assets - $1 - -
Debt
Net Debt $23,628,892 $22,464,766 $348,636 -
Total Debt $24,767,836 $25,108,964 $350,000 -
Long Term Debt And Capital Lease Obligation $13,127,122 $12,551,457 $350,000 -
Long Term Debt $12,600,000 $11,455,085 $350,000 -
Current Debt And Capital Lease Obligation $11,640,714 $12,557,507 $350,000 -
Current Debt $11,071,463 $12,038,017 $350,000 -
Other Current Borrowings $10,887,520 $11,927,816 $250,000 -
Liabilities
Total Liabilities Net Minority Interest $42,907,250 $50,598,204 $3,238,798 $5,250
Total Non Current Liabilities Net Minority Interest $13,127,122 $12,551,457 $350,000 $0
Current Liabilities $29,780,128 $38,046,747 $2,888,798 $5,250
Current Deferred Liabilities $488,229 $245,765 $0 -
Payables And Accrued Expenses $13,062,764 $22,131,005 $1,588,798 $5,250
Interest Payable $833,647 $504,152 $2,333 $0
Payables $11,915,635 $21,279,024 $1,106,465 $5,250
Accounts Payable $11,690,635 $6,334,254 $1,038,672 $5,250
Other Payable - $10,000,000 - -
Current Notes Payable - - $100,000 $0
Equity
Common Stock Equity $-12,447,801 $6,734,446 $-2,900,434 $-5,250
Total Equity Gross Minority Interest $-12,447,801 $6,734,446 $-2,900,434 $-5,250
Stockholders Equity $-12,447,801 $6,734,446 $-2,900,434 $-5,250
Retained Earnings $-111,031,690 $-9,757,160 $-2,900,934 $-5,250
Long Term Equity Investment - $17,671 $0 -
Other
Treasury Shares Number $982,121 - - -
Ordinary Shares Number $101,307,498 $51,944,397 $51,944,397 $51,944,397
Share Issued $101,307,498 $51,944,397 $51,944,397 $51,944,397
Tangible Book Value $-38,806,757 $-31,849,509 $-2,900,434 $-5,250
Invested Capital $11,223,662 $30,227,548 $-2,550,434 $-5,250
Working Capital $-26,960,912 $-22,878,079 $-2,550,434 $-5,250
Capital Lease Obligations $1,096,373 $1,615,862 $0 -
Total Capitalization $152,199 $18,189,531 $-2,550,434 $-5,250
Additional Paid In Capital $98,573,758 $16,486,501 $-3,972 -
Capital Stock $10,131 $5,105 $4,472 $0
Common Stock $10,131 $5,105 $4,472 $0
Long Term Capital Lease Obligation $527,122 $1,096,372 $0 -
Current Deferred Revenue $488,229 $245,765 $0 -
Current Capital Lease Obligation $569,251 $519,490 $0 -
Line Of Credit $183,943 $110,201 $0 -
Pensionand Other Post Retirement Benefit Plans Current $4,588,421 $3,112,470 $1,300,000 $0
Current Accrued Expenses $1,147,129 $851,981 $482,333 $0
Dueto Related Parties Current $225,000 $4,944,770 $67,793 $0
Goodwill $14,193,923 $16,219,929 $0 -
Net PPE $1,196,269 $1,916,308 $0 -
Accumulated Depreciation $-1,278,460 $-1,119,656 $0 -
Gross PPE $2,474,729 $3,035,964 $0 -
Leases $766,467 $766,467 $0 -
Other Properties $1,556,101 $2,117,336 - -
Machinery Furniture Equipment $152,161 $152,161 $0 -
Properties $0 $0 $0 -
Inventories Adjustments Allowances $-6,421,816 $-233,601 $0 -
Other Inventories $5,988,257 $6,717,373 - -
Finished Goods $2,072,985 $3,034,836 $0 -
Duefrom Related Parties Current $0 $1,021,000 $337,000 $0
Investments And Advances - $17,671 $0 -
Fetched: 2026-06-02
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-11,736,555 $-1,602,281 $-349,136 $0
Operating Activities
Operating Cash Flow $-10,855,029 $-1,224,993 $-349,136 $0
Cash Flow From Continuing Operating Activities $-10,855,029 $-1,224,993 $-349,136 $0
Operating Gains Losses $2,987,922 - - -
Investing Activities
Capital Expenditure $-881,526 $-377,288 - -
Investing Cash Flow $-881,526 $469,072 $0 -
Cash Flow From Continuing Investing Activities $-881,526 $469,072 $0 -
Capital Expenditure Reported $-881,526 $-377,288 - -
Net Other Investing Changes - $-85,008 - -
Financing Activities
Issuance Of Capital Stock $11,372,840 $10,000 $500 $0
Financing Cash Flow $10,750,790 $1,782,893 $350,500 $0
Cash Flow From Continuing Financing Activities $10,750,790 $1,782,893 $350,500 $0
Net Other Financing Charges $-841,602 $1,152,190 - -
Net Common Stock Issuance $11,372,840 $10,000 $500 $0
Common Stock Issuance $11,372,840 $10,000 $500 $0
Other
Repayment Of Debt $-24,747,409 $-135,777 $0 -
Issuance Of Debt $22,668,961 $756,480 $350,000 $0
Interest Paid Supplemental Data $3,110,776 $332,847 - -
Income Tax Paid Supplemental Data $0 $0 - -
End Cash Position $42,571 $1,028,336 $1,364 $0
Beginning Cash Position $1,028,336 $1,364 $0 $0
Changes In Cash $-985,765 $1,026,972 $1,364 -
Proceeds From Stock Option Exercised $2,298,000 $0 - -
Net Issuance Payments Of Debt $-2,078,448 $620,703 $350,000 $0
Net Short Term Debt Issuance $-4,024,478 $620,703 $0 $0
Short Term Debt Payments $-24,094,478 $-135,777 $0 -
Short Term Debt Issuance $20,070,000 $756,480 $0 $0
Net Long Term Debt Issuance $1,946,030 $0 $350,000 -
Long Term Debt Payments $-652,931 $0 - -
Long Term Debt Issuance $2,598,961 $0 $350,000 -
Net Business Purchase And Sale $0 $931,368 $0 -
Sale Of Business $0 $931,368 $0 -
Change In Working Capital $8,483,520 $3,342,085 $2,546,548 $5,250
Change In Other Working Capital $321,090 $3,326,274 $-269,207 -
Change In Other Current Liabilities $41,746 $22,091 $0 -
Change In Other Current Assets $0 $-587,539 $0 -
Change In Payables And Accrued Expense $5,429,464 $682,261 $2,815,755 $5,250
Change In Accrued Expense $3,233,642 $1,564,576 $1,782,333 $0
Change In Payable $2,195,822 $-882,315 $1,033,422 $5,250
Change In Account Payable $2,195,822 $-882,315 $1,033,422 $5,250
Change In Prepaid Assets $524 $11,435 $0 -
Change In Inventory $1,890,925 $-72,356 $0 -
Change In Receivables $799,771 $-40,081 $0 -
Changes In Account Receivables $799,771 $-40,081 $0 -
Other Non Cash Items $33,411 - - -
Stock Based Compensation $54,794,525 $1,081,106 $0 -
Provisionand Write Offof Assets $5,988,257 $0 - -
Asset Impairment Charge $14,920,802 $93,378 $0 -
Depreciation Amortization Depletion $3,211,064 $1,114,664 $0 -
Depreciation And Amortization $3,211,064 $1,114,664 $0 -
Amortization Cash Flow $3,052,260 $1,047,048 $0 -
Amortization Of Intangibles $3,052,260 $1,047,048 $0 -
Depreciation $158,804 $67,616 $0 -
Net Income From Continuing Operations $-101,274,530 $-6,856,226 $-2,895,684 $-5,250
Net Intangibles Purchase And Sale - $-377,288 $0 -
Purchase Of Intangibles - $-377,288 $0 -
Fetched: 2026-06-02